FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPMI8226 cells

Molecules and Cells

Volumn 10, Issue 5, 2000, Pages 552-556

  Kim, Do Kyun ^a   Cho, Eun Sook ^a   Yoon, Joo Heon ^b   Um, Hong Duck ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Fas; FLIP; IL 6; Myeloma cells

Indexed keywords

ANTIBODY; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CARRIER PROTEIN; CFLAR PROTEIN, HUMAN; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; INTERLEUKIN 6; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KINETICS; MULTIPLE MYELOMA; PHYSIOLOGY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MULTIPLE MYELOMA; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034739494     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-000-0552-0     Document Type: Article

References (21)

1. Ashkenazi, A. and Dixit, V. M. (1998) Death receptors; signaling and modulation. Science 281, 1305-1308.
2. Becker, S., Quay, J., and Soukup, J. (1991) Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147, 4307-4312.
3. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996) Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
4. Chauhan, D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D. W., and Anderson, K. C. (1997) Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89, 227-234.
5. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
6. L in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status. Br. J. Haematol. 97, 418-428.
7. L and initiates cell death. Proc. Natl. Acad. Sci. USA 94, 11333-11338.
8. Inohara, N., Koseki, T., Hu, Y., Chen, S., and Nunez, G. (1997) CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94, 10717-10722.
9. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. -L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., and Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
10. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S. -I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
11. Lee, B. R. and Um, H. -D. (1999) Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration. Exp. Cell Res. 248, 430-438.
12. Mangan, D., Welch, G. R., and Wahl, S. M. (1991) Lipopolysaccharide, tomuor necrosis factor α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146, 1541-1546.
13. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death. Cell 74, 609-619.
14. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. -M., Krammer, P. H., and Peter, M. E. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
15. Scaffidi, C., Schmitz, I., Krammer, P. H., and Peter, M. E. (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541-1548.
16. Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K., and Kishimoto, T. (1995) Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 85, 757-764.
17. Shima, Y., Nishimoto, N., Yoshizaki, K., and Kisaimoto, T. (1996) Fas antigen/APO-1 (CD95) expression on myeloma cells. Leukemia Lymphoma 23, 521-531.
18. L. Eur J. Immunol. 28, 4398-4408.
19. Srinivasula, S. M., Ahmad, M., Ottilie, S., Bullrich, F., Bamks, S., Wang, Y., Fernandes-Alnemri, T., Croce, C. M., Litwack, G., Tomaselli, K. J., Armstrong, R. C., and Alnemri, E. S. (1997) FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545.
20. Westendorf, J. J., Lammert, J. M., and Jelinek, D. F. (1995) Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85, 3566-3576.
21. Xu, F. -H., Sharma, S., Gardner, A., Tu, Y., Raitano, A., Sawyers, C., and Linchtenstein, A. (1998) Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 92, 241-251.